Your browser doesn't support javascript.
People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden.
Cillo, Anthony R; Somasundaram, Ashwin; Shan, Feng; Cardello, Carly; Workman, Creg J; Kitsios, Georgios D; Ruffin, Ayana T; Kunning, Sheryl; Lampenfeld, Caleb; Onkar, Sayali; Grebinoski, Stephanie; Deshmukh, Gaurav; Methe, Barbara; Liu, Chang; Nambulli, Sham; Andrews, Lawrence P; Duprex, W Paul; Joglekar, Alok V; Benos, Panayiotis V; Ray, Prabir; Ray, Anuradha; McVerry, Bryan J; Zhang, Yingze; Lee, Janet S; Das, Jishnu; Singh, Harinder; Morris, Alison; Bruno, Tullia C; Vignali, Dario A A.
  • Cillo AR; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Somasundaram A; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Shan F; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Cardello C; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Workman CJ; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Kitsios GD; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Ruffin AT; Integrative Systems Biology (ISB) Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
  • Kunning S; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Lampenfeld C; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Onkar S; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Grebinoski S; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Deshmukh G; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Methe B; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Liu C; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Nambulli S; Graduate Program of Microbiology and Immunology (PMI), University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
  • Andrews LP; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Duprex WP; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Joglekar AV; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Benos PV; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Ray P; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Ray A; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • McVerry BJ; Graduate Program of Microbiology and Immunology (PMI), University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
  • Zhang Y; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Lee JS; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Das J; Graduate Program of Microbiology and Immunology (PMI), University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
  • Singh H; Meso Scale Discovery, A division of Meso Scale Diagnostics, LLC, 1601 Research Boulevard, Rockville, MD 20850-3173, USA.
  • Morris A; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Bruno TC; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
  • Vignali DAA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
Cell Rep Med ; 2(12): 100476, 2021 12 21.
Article in English | MEDLINE | ID: covidwho-1631200
ABSTRACT
Despite extensive analyses, there remains an urgent need to delineate immune cell states that contribute to mortality in people critically ill with COVID-19. Here, we present high-dimensional profiling of blood and respiratory samples from people with severe COVID-19 to examine the association between cell-linked molecular features and mortality outcomes. Peripheral transcriptional profiles by single-cell RNA sequencing (RNA-seq)-based deconvolution of immune states are associated with COVID-19 mortality. Further, persistently high levels of an interferon signaling module in monocytes over time lead to subsequent concerted upregulation of inflammatory cytokines. SARS-CoV-2-infected myeloid cells in the lower respiratory tract upregulate CXCL10, leading to a higher risk of death. Our analysis suggests a pivotal role for viral-infected myeloid cells and protracted interferon signaling in severe COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Lung Type of study: Prognostic study Limits: Aged / Humans Language: English Journal: Cell Rep Med Year: 2021 Document Type: Article Affiliation country: J.xcrm.2021.100476

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Lung Type of study: Prognostic study Limits: Aged / Humans Language: English Journal: Cell Rep Med Year: 2021 Document Type: Article Affiliation country: J.xcrm.2021.100476